Feedback / Questions
Vicineum (oportuzumab monatox) - CARISMA Therap
https://www.businesswire.com/news/home/20230302005683/en/Sesen-Bio-Stockholders-Approve-Merger-with-Carisma-Therapeutics
Mar 2, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next